Rhinitis phenotypes and multimorbidities in the general population: the CONSTANCES cohort
Open Access
- 6 October 2022
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 61 (2) , 2200943
Abstract
Background: Scarce epidemiological studies have characterised allergic rhinitis (AR) and non-allergic rhinitis (NAR) in adults. In a population-based cohort, our aims were to 1) describe rhinitis, AR and NAR, and 2) explore how asthma and conjunctivitis may lead to the identification of novel rhinitis phenotypes.Methods: In this cross-sectional analysis, current rhinitis was defined as present in the last 12 months using a questionnaire from the French CONSTANCES cohort. Participants with current rhinitis reporting nasal allergies were considered as AR, otherwise as NAR. We described AR and NAR phenotypes, and their phenotypes including co-occurrence with ever-asthma and ever-conjunctivitis.Results: Among the 20 772 participants included in this analysis (mean±sdage 52.6±12.6 years; 55.2% female), crude prevalences of AR and NAR were 28.0% and 10.9%. AR participants more frequently reported persistent rhinitis (31.6%versus25.1%) and moderate-to-severe rhinitis (40.1%versus24.2%) than NAR participants. Among AR or NAR participants, those with ever-asthma reported more moderate-to-severe rhinitis. Participants with AR, ever-asthma and ever-conjunctivitis had an earlier age of rhinitis onset, more severe rhinitis and higher eosinophil counts than participants in other groups. Results were replicated in another cohort.Conclusions: In this large population-based cohort, 40% reported current rhinitis, with a lower prevalence of moderate-to-severe rhinitis than in clinical practice. For the first time in a general adult population, we showed that AR and NAR alone or in combination with asthma or in combination with asthma and conjunctivitis are different phenotypes. These results provide new insights on how best to manage rhinitis and its multimorbidities.Keywords
Funding Information
- L'Oreal USA
- Caisse Nationale d'Assurance Maladie
- Merck Sharp and Dohme United Kingdom
- Agence de l'Environnement et de la Maîtrise de l'Energie
- AstraZeneca
- Agence Nationale de la Recherche (ANR-11-INBS-0002)
- Université Paris-Saclay
This publication has 33 references indexed in Scilit:
- Characterization of Rhinitis According to the Asthma Status in Adults Using an Unsupervised Approach in the EGEA StudyPLOS ONE, 2015
- Local IgE in non‐allergic rhinitisClinical & Experimental Allergy, 2014
- Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needsJournal of Allergy and Clinical Immunology, 2012
- Management of Rhinitis: Allergic and Non-AllergicAllergy, Asthma & Immunology Research, 2011
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*Allergy, 2008
- Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adultsAllergy, 2007
- Prevalence, classification and perception of allergic and nonallergic rhinitis in BelgiumAllergy, 2006
- Characteristics of intermittent and persistent allergic rhinitis: DREAMS study groupClinical & Experimental Allergy, 2005
- Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS)European Respiratory Journal, 1996
- International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methodsEuropean Respiratory Journal, 1995